Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze STOK stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate STOK investment potential.

What is STOK stock price today?

Get real-time STOK stock price, historical data, and price charts on Financhill. Track STOK performance with our advanced analysis tools.

Is STOK a good investment?

Evaluate STOK investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy STOK stock?

To buy STOK stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of STOK?

View detailed market capitalization data and company valuation metrics for STOK on our comprehensive analysis page.

What is the P/E ratio of STOK?

Use our fundamental analysis tools to view STOK P/E ratio and compare valuation metrics with industry peers.

What are STOK earnings?

View STOK earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Stoke Therapeutics, Inc. Stock Predictions

14K Investors Got In Earlier. You Still Can.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Buy

STOK
Stoke Therapeutics, Inc.

Last Price:

$31.98

Seasonality Move:

-3.69%

7 Day Trial

ALL ACCESS PASS

$ 7

Share Price Moved. Momentum Hasn't Slowed.

Stoke Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Stoke Therapeutics, Inc. has on average historically risen by 42.2% based on the past 6 years of stock performance.
Stoke Therapeutics, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Is Stoke Therapeutics, Inc. Stock Undervalued?

The current Stoke Therapeutics, Inc. [STOK] share price is $32.86. The Score for STOK is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
STOK is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Stoke Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Stoke Therapeutics, Inc. has on average historically risen by 42.2% based on the past 6 years of stock performance.

Stoke Therapeutics, Inc. Stock Rating

Buy

Stoke Therapeutics, Inc. (STOK) is a Buy

Is Stoke Therapeutics, Inc. overpriced?

Stoke Therapeutics, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Stoke Therapeutics, Inc. Stock Price History

Is STOK stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and STOK is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

stoketherapeutics.com

52-Week Data

52-Week High:

38.69

52-Week Low:

5.35

Prediction Charts

Market Cap:

1.9B

Price in USD:

32.86

Volume:

852K

Beta:

0.95

Technical Analysis

SMA50:

30.14

SMA100:

24.96

SMA200:

17.37

52-Wk Change:

171.57%

Stock Predictions

Is Stoke Therapeutics, Inc. stock public?

Yes, Stoke Therapeutics, Inc. is a publicly traded company.
What is the Stoke Therapeutics, Inc. stock quote today?

The Stoke Therapeutics, Inc. stock price is 32.86 USD today.
How to buy Stoke Therapeutics, Inc. stock online?

You can buy Stoke Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-28	31.22	30.91	31.44	30.28
Dec-1	30.73	30.09	30.73	29.32
Dec-2	29.80	29.81	30.71	28.74
Dec-3	29.81	30.96	31.23	29.70
Dec-4	30.23	31.05	31.54	30.10
Dec-5	31.13	30.87	32.09	30.26
Dec-8	31.29	33.00	33.30	30.90
Dec-9	32.73	30.47	33.34	30.37
Dec-10	31.11	34.15	35.34	30.17
Dec-11	33.85	33.09	35.40	32.93
Dec-12	33.33	32.39	33.77	32.26
Dec-15	33.13	32.98	35.43	32.47
Dec-16	32.52	33.61	33.93	32.40
Dec-17	33.60	32.86	34.05	32.43

Stoke Therapeutics, Inc. Earnings

Stoke Therapeutics, Inc. Earnings Report: Per Share Stoke Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Stoke Therapeutics, Inc. Forecast Revenue Growth

Stoke Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Stoke Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.07 per share, and a decrease next year of $3.13 per share.

* Stoke Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.